Xia Gao

Xia Gao

Auto-generated profile, based on publicly available information

Xia Gao

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2019 in Nature Reviews Cancer
Verified
Journal Article
Closed access
PDF file
SSSydney M. Sanderson
Sydney M. Sanderson
XGXia Gao
Xia Gao
ZDZiwei Dai
Ziwei Dai
JLJason W. Locasale
Jason W. Locasale

5 August 2019 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
PLP. Kent Langston
P. Kent Langston
ANAya Nambu
Aya Nambu
JJJonathan Jung
Jonathan Jung
MSMunehiko Shibata
Munehiko Shibata
HAH. Ibrahim Aksoylar
H. Ibrahim Aksoylar
THTiffany Horng
Tiffany Horng

4 January 2019 in Science Immunology
Verified
Journal Article
Closed access
PDF file
LGLelisa F. Gemta
Lelisa F. Gemta
PSPeter J. Siska
Peter J. Siska
MNMarin E. Nelson
Marin E. Nelson
XGXia Gao
Xia Gao
XLXiaojing Liu
Xiaojing Liu
TBTimothy N Bullock
Timothy N Bullock
Impaired activity of enolase 1 limits glycolysis and effector function of tumor-infiltrating CD8 + T cells.

7 August 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
QXQing Xu
Qing Xu
YLYuanyuan Li
Yuanyuan Li
XGXia Gao
Xia Gao
KKKai Kang
Kai Kang
JWJason G. Williams
Jason G. Williams
XLXiaoling Li
Xiaoling Li
Methionine restriction, a dietary regimen that protects against metabolic diseases and aging, represses cancer growth and improves cancer therapy. However, the response of different cancer cells to this nutritional manipulation is highly variable, and the molecular determinants of this heterogeneity remain poorly understood. Here we report that hepatocyte nuclear factor 4α (HNF4α) dictates the sensitivity of liver cancer to methionine restriction. We show that hepatic sulfur amino acid (SAA) metabolism is under transcriptional control of HNF4α. Knocking down HNF4α or SAA enzymes in HNF4α-positive epithelial liver cancer lines impairs SAA metabolism, increases resistance to methionine restriction or sorafenib, promotes epithelial-mesenchymal transition, and induces cell migration. Conversely, genetic or metabolic restoration of the transsulfuration pathway in SAA metabolism significantly alleviates the outcomes induced by HNF4α deficiency in liver cancer cells. Our study identifies HNF4α as a regulator of hepatic SAA metabolism that regulates the sensitivity of liver cancer to methionine restriction.

22 March 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
LXLingfan Xu
Lingfan Xu
YYYu Yin
Yu Yin
YLYanjing Li
Yanjing Li
XCXufeng Chen
Xufeng Chen
YCYan Chang
Yan Chang
JHJiaoti Huang
Jiaoti Huang
Significance: We report that androgen receptor (AR) promotes glutaminase 1 (GLS1) expression and glutamine utilization to support the survival of prostate cancer (PCa) cells. Hormonal therapy inhibits AR and decreases GLS1 expression and glutamine utilization to achieve therapeutic effect. Our results suggest that eventually the tumor cells switch GLS1 expression from the AR-dependent KGA isoform to the androgen-independent and enzymatically more potent GAC isoform, which increases glutamine utilization and can contribute to the development of castration-resistant PCa. Our work has discovered a previously unknown AR function, a metabolic mechanism of hormonal therapy and an important therapeutic target more specific than AR. Targeting GLS1 may achieve similar therapeutic efficacy but without the side effects resulting from inhibiting AR’s other important physiologic functions.

26 October 2022 in Cancer Immunology Research
Verified
Journal Article
Closed access
PDF file
PJPatrick K. Juras
Patrick K. Juras
LRLuigi Racioppi
Luigi Racioppi
DMDebarati Mukherjee
Debarati Mukherjee
SASandeep Artham
Sandeep Artham
XGXia Gao
Xia Gao
DMDonald P McDonnell
Donald P McDonnell
Calcium/calmodulin-dependent protein kinase kinase 2 (CaMKK2) is a key regulator of energy homeostasis in several cell types. Expression of this enzyme in tumor cells promotes proliferation and migration, and expression in tumor-associated immune cells facilitates M2 macrophage polarization and the development of myeloid-derived suppressor cells. Thus, there has been interest in developing CaMKK2 inhibitors as potential anticancer therapeutics. One impediment to clinical development of these agents is that the roles of CaMKK2 in other cellular compartments within the tumor immune microenvironment remain to be established. We report herein that CaMKK2 is expressed at low basal levels in natural killer (NK) cells but is upregulated in tumor-infiltrating NK cells where it suppresses apoptosis and promotes proliferation. NK cell–intrinsic deletion of CaMKK2 increased metastatic progression in several murine models, establishing a critical role for this enzyme in NK cell–mediated antitumor immunity. Ablation of the CaMKK2 protein, but not inhibition of its kinase activity, resulted in decreased NK-cell survival. These results indicate an important scaffolding function for CaMKK2 in NK cells and suggest that competitive CaMKK2 inhibitors and ligand-directed degraders (LDD) are likely to have distinct therapeutic utilities. Finally, we determined that intracellular lactic acid is a key driver of CaMKK2 expression, suggesting that upregulated expression of this enzyme is an adaptive mechanism by which tumor-infiltrating NK cells mitigate the deleterious effects of a lactic acid–rich tumor microenvironment. The findings of this study should inform strategies to manipulate the CaMKK2-signaling axis as a therapeutic approach in cancer.